Global Intracranial Pressure Monitoring Devices Market

Intracranial Pressure Monitoring Devices Market Size, Share, Growth Analysis, By Technique(Invasive, and Non-invasive), By Application(Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2537 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 69 | Figures: 75

Intracranial Pressure Monitoring Devices Market Competitive Landscape

The global intracranial pressure monitoring devices market is highly contested with primary players seeking technological advancements and product diversification. This market is dominated by companies like Medtronic, Integra LifeSciences, Raumedic, Abbott Laboratories, and Neurosign. These companies are also pursuing advanced monitoring solutions that incorporate both invasive and non-invasive devices to improve patient outcomes. Strategic partnerships, acquisitions, and constant research to increase the supply capacity are some of the basics employed to fortify their positions and satisfy the demand in various health care environments. 

Intracranial Pressure Monitoring Devices Market Top Player’s Company Profiles

  • Johnson & Johnson Services, Inc. (US)
  • Sophysa S.A. (France)
  • Spiegelberg GmbH & Co. KG (Germany)
  • Raumedic AG (Germany)
  • HeadSense Medical Ltd. (Israel)
  • Haiying Medical Technology Co., Ltd. (China)
  • Vittamed Corporation (Lithuania)
  • Orsan Medical Technologies (Turkey)
  • SOPHYSA MEDICAL (France)
  • Möller Medical GmbH (Germany)
  • Gaeltec Devices Ltd. (UK)
  • Cerenovus (Johnson & Johnson) (US)
  • NeuroWave Systems Inc. (US)
  • DePuy Synthes (Johnson & Johnson) (US)
  • Gaeltec Devices Ltd. (UK)
  • Raumedic Inc. (US)
  • Yokogawa Electric Corporation (Japan)

Intracranial Pressure Monitoring Devices Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Intracranial Pressure Monitoring Devices Market size was valued at USD 1.60 Billion in 2022 and is poised to grow from USD 1.72 Billion in 2023 to USD 3.15 Billion by 2031, at a CAGR of 7.80% during the forecast period (2024-2031).

The global intracranial pressure monitoring devices market is highly contested with primary players seeking technological advancements and product diversification. This market is dominated by companies like Medtronic, Integra LifeSciences, Raumedic, Abbott Laboratories, and Neurosign. These companies are also pursuing advanced monitoring solutions that incorporate both invasive and non-invasive devices to improve patient outcomes. Strategic partnerships, acquisitions, and constant research to increase the supply capacity are some of the basics employed to fortify their positions and satisfy the demand in various health care environments.  'Medtronic plc (US)', 'Integra LifeSciences Corporation (US)', 'Johnson & Johnson Services, Inc. (US)', 'Natus Medical Incorporated (US)', 'Sophysa S.A. (France)', 'Spiegelberg GmbH & Co. KG (Germany)', 'Raumedic AG (Germany)', 'HeadSense Medical Ltd. (Israel)', 'Haiying Medical Technology Co., Ltd. (China)', 'Vittamed Corporation (Lithuania)', 'Orsan Medical Technologies (Turkey)', 'SOPHYSA MEDICAL (France)', 'Möller Medical GmbH (Germany)', 'Gaeltec Devices Ltd. (UK)', 'Cerenovus (Johnson & Johnson) (US)', 'NeuroWave Systems Inc. (US)', 'DePuy Synthes (Johnson & Johnson) (US)', 'Gaeltec Devices Ltd. (UK)', 'Raumedic Inc. (US)', 'Yokogawa Electric Corporation (Japan)'

The growing incidence of neurological conditions, such as traumatic brain injury, stroke, and intracerebral hemorrhage, is a major driver for the global intracranial pressure monitoring devices market. Since these situations often result in increased pressure inside the skull, there is an increasing demand worldwide for precise measuring technologies in order to control patient results. 

Rise of Non-Invasive Monitoring Methods: The movement associated with non-invasive intracranial pressure monitoring devices is becoming renaissance owing to sensor technology and even imaging techniques supporting the method making it more accurate and achievable. These devices are being adopted in medical practice largely due to reduced risk to the patient, quicker recovery times, and greater comfort. 

North America is dominating the global intracranial pressure monitoring devices market due to advanced healthcare infrastructure, a high prevalence of neurological disorders, and strong research and development activities. The region is also buoyed up by modern equipment, a solid regulatory environment, and considerable investment in healthcare, which all contribute to the uptake of advanced intracranial pressure monitoring devices. Moreover, in North America, there are a significant number of owing hospitals and trauma care facilities with sophisticated equipment used for the management of injuries, such as that resultant from traumatic brain injuries and strokes. There is a growing trend towards optimizing treatment outcomes for patients and minimizing expenses incurred in the treatment services. This trend in turn increases the pace at which intracranial pressure monitoring devices are demanded in the region. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Intracranial Pressure Monitoring Devices Market

Report ID: SQMIG35A2537

$5,300
BUY NOW GET FREE SAMPLE